MiR-26a-5p Serves as an Oncogenic MicroRNA in Non-Small Cell Lung Cancer by Targeting FAF1.

Ming-Fan YeDong LinWu-Jin LiHai-Peng XuJing Zhang

Published in: Cancer management and research (2020)

Taken together, we show that miR-26a-5p functions as an oncogenic microRNA in NSCLC by targeting FAF1 and may serve as a potential target for NSCLC treatment.

Keyphrases

small cell lung cancer
advanced non small cell lung cancer
transcription factor
brain metastases
combination therapy
epidermal growth factor receptor
climate change
replacement therapy
tyrosine kinase